Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Keith A. Goldan

CFO at Syndax Pharmaceuticals Inc (SNDX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $137K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 2SEC SNDXSyndax Pharmaceuticals Inc Sell 1,177139,252 held (−1%) $18.99 $22K -32.1%
Feb 10SEC SNDXSyndax Pharmaceuticals Inc Sell 3,410140,429 held (−2%) $21.03 $72K -38.7%
Feb 6SEC SNDXSyndax Pharmaceuticals Inc Sell 2,082143,839 held (−1%) $20.62 $43K -37.4%